Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (12): 1111-1113.DOI: 10.3969/j.issn.1673-8640.2019.12.011

Previous Articles     Next Articles

Role of serum carbohydrate antigen 153 determination in the disease course of megaloblastic anemia

YAN Kuanghua, ZHANG Tiansheng   

  1. The First Affiliated Hospital of Henan University,Kaifeng 475001,Henan,China
  • Received:2018-11-07 Online:2019-12-30 Published:2020-01-03

Abstract:

Objective To investigate the role of serum carbohydrate antigen 153(CA153) determination in the disease course of megaloblastic anemia(MA). Methods A total of 48 MA patients without folic acid(FA) and vitamin B12(VitB12) supplement treatment were enrolled as research group,and 32 healthy subjects were enrolled as control group. The CA153 levels were determined in research group before and after treatment and control group. The correlations of CA153 with other determination indicators were evaluated. Results The level of CA153 in research group before treatment [(51.10±5.77)U/mL] was higher than that in control group [(20.22±4.69)U/mL](P<0.001). After FA and VitB12 supplement treatment for 2-6 weeks,CA153 level in research group decreased [(21.92±4.52)U/mL](P<0.001),which had no statistical significance compared with that in control group(P=0.108). CA153 was negatively correlated with hemoglobin(Hb)(r=-0.882,P<0.001),and it was positively correlated with lactate dehydrogenase(LDH)(r=0.455,P=0.001). Conclusions Serum CA153 levels increase in patients with MA. Serum CA153 determination can provide a reference for the early diagnosis of MA.

Key words: Carbohydrate antigen 153, Megaloblastic anemia, Folic acid, Vitamin B12

CLC Number: